市場調查報告書

全球生技藥品市場

Biologics Global Market Report 2020-30: Covid 19 Impact and Recovery

出版商 The Business Research Company 商品編碼 603063
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
全球生技藥品市場 Biologics Global Market Report 2020-30: Covid 19 Impact and Recovery
出版日期: 2020年05月19日內容資訊: 英文
簡介

本報告提供全球生技藥品市場相關調查分析,提供市場特徵,市場規模·成長率,市場區隔,各地區·各國明細,競爭情形,趨勢與策略等系統性資訊。

第1章 市場特徵

第2章 市場規模·成長率

  • 市場成長率 (實際成果)
  • 市場成長率 (預測)

第3章 趨勢與策略

第4章 大環境分析

  • 政治
  • 經濟
  • 社會
  • 技術性
  • 法律
  • 環境的

第5章 客戶資訊

第6章 各地區·各國分析

  • 各地區
  • 實際成果與預測:各地區
  • 成長率與市場佔有率比較:各地區
  • 各國
  • 實際成果與預測:各國
  • 成長率與市場佔有率比較:各國

第7章 市場區隔:各類型

第8章 市場區隔:各市場區隔

第9章 宏觀經濟要素的比較

  • 市場規模,佔GDP比率:全球
  • 每人平均支出:全球

第10章 宏觀經濟要素的比較:各國

  • 市場規模,佔GDP比率:各國
  • 每人平均支出:各國

第11章 指標的比較

第12章 亞太地區

第13章 西歐

第14章 東歐

第15章 北美

第16章 南美

第17章 中東

第18章 非洲

第19章 競爭情形

  • 企業簡介
  • Amgen
  • AbbVie Inc
  • Johnson & Johnson
  • Bristol-Myers Squibb Company
  • Pfizer Inc

第20章 主要M&A

第21章 市場背景:醫療市場

第22章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

‘Biologics Global Market Report 2020-30: Covid 19 Impact and Recovery ’ from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global biologics market as it emerges from the Covid 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the biologics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Biologics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider biologics market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The biologics market section of the report gives context. It compares the biologics market with other segments of the pharmaceuticals market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, biologics indicators comparison.

Scope

Markets Covered:

1) By Type: Monoclonal Antibodies (MAbS); Therapeutic Proteins; Vaccines

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others

3) By Route Of Administration: Oral; Parenteral; Others

4) By Drug Classification: Branded Drugs; Generic Drugs

5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Subsegments Covered: Anti-Cancer MAbS; Immunological MAbS; Anti-Infective Monoclonal Antibodies (MAbs); Neuropharmacological MABS; Cardiovascular And Cerebrovascular MAbS; Others - Monoclonal Antibodies (MAbs); Metabolic Disorders Therapeutic Proteins; Cancer Therapeutic Proteins; Cardiovascular Therapeutic Proteins; Immunological Therapeutic Proteins; Others - Therapeutic Proteins; Anti-Infective Vaccines; Autoimmunity Vaccines; Others-Vaccines

Companies Mentioned: Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Bristol-Myers Squibb; GlaxoSmithKline Plc.; AbbVie

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, biologics indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Report Structure

3. Biologics Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Biologics Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Biologics Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Biologics Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Biologics Market Trends And Strategies

8. Biologics Market Size And Growth

  • 8.1. Market Size
  • 8.2. Historic Market Growth, Value ($ Billion)
    • 8.2.1. Drivers Of The Market
    • 8.2.2. Restraints On The Market
  • 8.3. Forecast Market Growth, Value ($ Billion)
    • 8.3.1. Drivers Of The Market
    • 8.3.2. Restraints On The Market

9. Biologics Market Regional Analysis

  • 9.1. Global Biologics Market, 2019, By Region, Value ($ Billion)
  • 9.2. Global Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • 9.3. Global Biologics Market, Growth And Market Share Comparison, By Region

10. Biologics Market Segmentation

  • 10.1. Global Biologics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Monoclonal Antibodies (MAbS)

Therapeutic Proteins

Vaccines

  • 10.2. Global Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Hospital Pharmacies

Retail Pharmacies/ Drug Stores

Others

  • 10.3. Global Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Oral

Parenteral

Others

  • 10.4. Global Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Branded Drugs

Generic Drugs

  • 10.5. Global Biologics Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Prescription-Based Drugs

Over-The-Counter Drugs

11. Biologics Market Segments

  • 11.1. Global Monoclonal Antibodies (MAbS) Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion) - Anti-Cancer MAbS; Immunological MAbS; Anti-Infective Monoclonal Antibodies (MAbs); Neuropharmacological MABS; Cardiovascular And Cerebrovascular MAbS; Others - Monoclonal Antibodies (MAbs)
  • 11.2. Global Therapeutic Proteins Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion) - Metabolic Disorders Therapeutic Proteins; Cancer Therapeutic Proteins; Cardiovascular Therapeutic Proteins; Immunological Therapeutic Proteins; Others - Therapeutic Proteins
  • 11.3. Global Vaccines Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion) - Anti-Infective Vaccines; Autoimmunity Vaccines; Others-Vaccines

12. Biologics Market Metrics

  • 12.1. Biologics Market Size, Percentage Of GDP, 2015-2023, Global
  • 12.2. Per Capita Average Biologics Market Expenditure, 2015-2023, Global

13. Asia-Pacific Biologics Market

  • 13.1. Asia-Pacific Biologics Market Overview
  • 13.2. Asia-Pacific, Biologics Market, 2019, By Country, Value ($ Billion)
  • 13.3. Asia-Pacific, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 13.4. Asia-Pacific, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 13.5. Asia-Pacific, Biologics Market Metrics
    • 13.5.1. Per Capita Average Biologics Expenditure, 2015-2023, Asia-Pacific Countries
    • 13.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Asia-Pacific Countries
    • 13.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Asia-Pacific Countries
  • 13.6. Asia-Pacific Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 13.7. Asia-Pacific Biologics Market: Country Analysis
    • 13.7.1. China Biologics Market
      • 13.7.1.1. China Biologics Market Overview
      • 13.7.1.2. China Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.1.3. China Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.2. Australia Biologics Market
      • 13.7.2.1. Australia Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.2.2. Australia Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.3. Hong Kong Biologics Market
      • 13.7.3.1. Hong Kong Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.4. India Biologics Market
      • 13.7.4.1. India Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.4.2. India Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.5. Indonesia Biologics Market
      • 13.7.5.1. Indonesia Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.5.2. Indonesia Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.6. Japan Biologics Market
      • 13.7.6.1. Japan Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.6.2. Japan Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.7. Malaysia Biologics Market
      • 13.7.7.1. Malaysia Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.8. New Zealand Biologics Market
      • 13.7.8.1. New Zealand Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.9. Philippines Biologics Market
      • 13.7.9.1. Philippines Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.10. Singapore Biologics Market
      • 13.7.10.1. Singapore Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.11. South Korea Biologics Market
      • 13.7.11.1. South Korea Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.11.2. South Korea Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.12. Thailand Biologics Market
      • 13.7.12.1. Thailand Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.13. Vietnam Biologics Market
      • 13.7.13.1. Vietnam Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

14. Western Europe Biologics Market

  • 14.1. Western Europe Biologics Market Overview
  • 14.2. Western Europe, Biologics Market, 2019, By Country, Value ($ Billion)
  • 14.3. Western Europe, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 14.4. Western Europe, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 14.5. Western Europe, Biologics Market Metrics
    • 14.5.1. Per Capita Average Biologics Expenditure, 2015-2023, Western Europe Countries
    • 14.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Western Europe Countries
    • 14.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Western Europe Countries
  • 14.6. Western Europe Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 14.7. Western Europe Biologics Market: Country Analysis
    • 14.7.1. Austria Biologics Market
      • 14.7.1.1. Austria Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.2. Belgium Biologics Market
      • 14.7.2.1. Belgium Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.3. Denmark Biologics Market
      • 14.7.3.1. Denmark Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.4. Finland Biologics Market
      • 14.7.4.1. Finland Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.5. France Biologics Market
      • 14.7.5.1. France Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 14.7.5.2. France Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.6. Germany Biologics Market
      • 14.7.6.1. Germany Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 14.7.6.2. Germany Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.7. Ireland Biologics Market
      • 14.7.7.1. Ireland Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.8. Italy Biologics Market
      • 14.7.8.1. Italy Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.9. Netherlands Biologics Market
      • 14.7.9.1. Netherlands Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.10. Norway Biologics Market
      • 14.7.10.1. Norway Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.11. Portugal Biologics Market
      • 14.7.11.1. Portugal Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.12. Spain Biologics Market
      • 14.7.12.1. Spain Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.13. Sweden Biologics Market
      • 14.7.13.1. Sweden Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.14. Switzerland Biologics Market
      • 14.7.14.1. Switzerland Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.15. UK Biologics Market
      • 14.7.15.1. UK Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 14.7.15.2. UK Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

15. Eastern Europe Biologics Market

  • 15.1. Eastern Europe Biologics Market Overview
  • 15.2. Eastern Europe, Biologics Market, 2019, By Country, Value ($ Billion)
  • 15.3. Eastern Europe, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 15.4. Eastern Europe, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 15.5. Eastern Europe, Biologics Market Metrics
    • 15.5.1. Per Capita Average Biologics Expenditure, 2015-2023, Eastern Europe Countries
    • 15.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Eastern Europe Countries
    • 15.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Eastern Europe Countries
  • 15.6. Eastern Europe Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 15.7. Eastern Europe Biologics Market: Country Analysis
    • 15.7.1. Czech Republic Biologics Market,
      • 15.7.1.1. Czech Republic Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 15.7.2. Poland Biologics Market
      • 15.7.2.1. Poland Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 15.7.3. Romania Biologics Market
      • 15.7.3.1. Romania Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 15.7.4. Russia Biologics Market
      • 15.7.4.1. Russia Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 15.7.4.2. Russia Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

16. North America Biologics Market

  • 16.1. North America Biologics Market Overview
  • 16.2. North America, Biologics Market, 2019, By Country, Value ($ Billion)
  • 16.3. North America, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 16.4. North America, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 16.5. North America, Biologics Market Metrics
    • 16.5.1. Per Capita Average Biologics Expenditure, 2015-2023, North America Countries
    • 16.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, North America Countries
    • 16.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, North America Countries
  • 16.6. North America Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 16.7. North America Biologics Market: Country Analysis
    • 16.7.1. Canada Biologics Market
      • 16.7.1.1. Canada Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.2. Mexico Biologics Market
      • 16.7.2.1. Mexico Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.3. USA Biologics Market
      • 16.7.3.1. USA Biologics Market Overview
      • 16.7.3.2. USA Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 16.7.3.3. USA Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

17. South America Biologics Market

  • 17.1. South America Biologics Market Overview
  • 17.2. South America, Biologics Market, 2019, By Country, Value ($ Billion)
  • 17.3. South America, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 17.4. South America, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 17.5. South America, Biologics Market Metrics
    • 17.5.1. Per Capita Average Biologics Expenditure, 2015-2023, South America Countries
    • 17.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, South America Countries
    • 17.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, South America Countries
  • 17.6. South America Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 17.7. South America Biologics Market: Country Analysis
    • 17.7.1. Argentina Biologics Market
      • 17.7.1.1. Argentina Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.2. Brazil Biologics Market
      • 17.7.1.1. Brazil Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 17.7.2.2. Brazil Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.3. Chile Biologics Market
      • 17.7.3.1. Chile Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.4. Colombia Biologics Market
      • 17.7.4.1. Colombia Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.5. Peru Biologics Market
      • 17.7.5.1. Peru Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.6. Venezuela Biologics Market
      • 17.7.6.1. Venezuela Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

18. Middle East Biologics Market

  • 18.1. Middle East Biologics Market Overview
  • 18.2. Middle East, Biologics Market, 2019, By Country, Value ($ Billion)
  • 18.3. Middle East, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 18.4. Middle East, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 18.5. Middle East, Biologics Market Metrics
    • 18.5.1. Per Capita Average Biologics Expenditure, 2015-2023, Middle East Countries
    • 18.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Middle East Countries
    • 18.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Middle East Countries
  • 18.6. Middle East Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 18.7. Middle East Biologics Market: Country Analysis
    • 18.7.1. Saudi Arabia Biologics Market
      • 18.7.1.1. Saudi Arabia Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 18.7.2. Israel Biologics Market
      • 18.7.2.1. Israel Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 18.7.3. Turkey Biologics Market
      • 18.7.3.1. Turkey Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 18.7.4. UAE Biologics Market
      • 18.7.4.1. UAE Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

19. Africa Biologics Market

  • 19.1. Africa Biologics Market Overview
  • 19.2. Africa, Biologics Market, 2019, By Country, Value ($ Billion)
  • 19.3. Africa, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 19.4. Africa, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 19.5. Africa, Biologics Market Metrics
    • 19.5.1. Per Capita Average Biologics Expenditure, 2015-2023, Africa Countries
    • 19.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Africa Countries
    • 19.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Africa Countries
  • 19.6. Africa Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 19.7. Africa Biologics Market: Country Analysis
    • 19.7.1. Egypt Biologics Market
      • 19.7.1.1. Egypt Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 19.7.2. Nigeria Biologics Market
      • 19.7.2.1. Nigeria Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 19.7.3. South Africa Biologics Market
      • 19.7.3.1. South Africa Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

20. Biologics Market Competitive Landscape

  • 20.1. Competitive Market Overview
  • 20.2. Market Shares
  • 20.3. Company Profiles
    • 20.3.1. Johnson & Johnson
      • 20.3.1.1. Company Overview
      • 20.3.1.2. Products And Services
      • 20.3.1.3. Strategy
      • 20.3.1.4. Financial Performance
    • 20.3.2. F. Hoffmann-La Roche Ltd.
      • 20.3.2.1. Company Overview
      • 20.3.2.2. Products And Services
      • 20.3.2.3. Strategy
      • 20.3.2.4. Financial Performance
    • 20.3.3. Bristol-Myers Squibb
      • 20.3.3.1. Company Overview
      • 20.3.3.2. Products And Services
      • 20.3.3.3. Strategy
      • 20.3.3.4. Financial Performance
    • 20.3.4. GlaxoSmithKline Plc.
      • 20.3.4.1. Company Overview
      • 20.3.4.2. Products And Services
      • 20.3.4.3. Strategy
      • 20.3.4.4. Financial Performance
    • 20.3.5. AbbVie
      • 20.3.5.1. Company Overview
      • 20.3.5.2. Products And Services
      • 20.3.5.3. Strategy
      • 20.3.5.4. Financial Performance

21. Key Mergers And Acquisitions In The Biologics Market

22. Market Background: Pharmaceuticals Market

  • 22.1. Pharmaceuticals Market Characteristics
  • 22.2. Pharmaceuticals Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F Growth, By Segment, Value ($ Billion), Global
  • 22.3. Global Pharmaceuticals Market, 2019, By Region, Value ($ Billion)
  • 22.4. Global Pharmaceuticals Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • 22.5. Global Pharmaceuticals Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)

23. Recommendations

  • 23.1. Global Biologics Market In 2023- Growth Countries
  • 23.2. Global Biologics Market In 2023- Growth Segments
  • 23.3. Global Biologics Market In 2023- Growth Strategies

24. Appendix

  • 24.1. NAICS Definitions Of Industry Covered In This Report
  • 24.2. Abbreviations
  • 24.3. Currencies
  • 24.4. Research Inquiries
  • 24.5. The Business Research Company

25. Copyright And Disclaimer